Recurrence Rate of Differentiated Thyroid Cancer in Patients Underwent Post-Radioactive Iodine Ablation Therapy at the Service De Medecine Nucleaire, Centre Hospital Universitaire De Bab El Oued, Algiers, Algeria
No Thumbnail Available
Date
2025-05-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
Introduction: Differentiated thyroid cancer (DTC) is primarily derived from follicular cells and accounts for over 90% of thyroid malignancies. Despite a high disease-free survival rate (98%) following radioactive iodine (RAI) ablation therapy, recurrence rates vary significantly globally.
Objective: This study aimed to assess the recurrence rate of DTC through a retrospective crosssectional analysis of patients who underwent RAI therapy.
Methods: A sample size of 100 patients with DTC treated at the Service de Médecine Nucléaire was analyzed using specific inclusion/exclusion criteria.
Result: The recurrence rate post-RAI therapy was 11% with 6/11(55%) cytological confirmed and 5/11(45%) not confirmed. The study show no associated risk factor for recurrence.
Conclusion: the study shows recurrence rate was in the low-risk group but higher than the local region. No predictor associate with recurrence.
Recommendation: revise management principle and risk stratification. PET/CT must be included in the follow-up.
Description
Keywords
Differentiated thyroid cancer Radioactive Iodine recurrence